Literature DB >> 30446565

Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Gautam N Shenoy1, Jenni Loyall1, Charles S Berenson1,2,3, Raymond J Kelleher1, Vandana Iyer4, Sathy V Balu-Iyer4, Kunle Odunsi5, Richard B Bankert6.   

Abstract

The tumor microenvironment is rendered immunosuppressive by a variety of cellular and acellular factors that represent potential cancer therapeutic targets. Although exosomes isolated from ovarian tumor ascites fluids have been previously reported to induce a rapid and reversible T cell arrest, the factors present on or within exosomes that contribute to immunosuppression have not been fully defined. In this study, we establish that GD3, a ganglioside expressed on the surface of exosomes isolated from human ovarian tumor ascites fluids, is causally linked to the functional arrest of T cells activated through their TCR. This arrest is inhibited by Ab blockade of exosomal GD3 or by the removal of GD3+ exosomes. Empty liposomes expressing GD3 on the surface also inhibit the activation of T cells, establishing that GD3 contributes to the functional arrest of T cells independent of factors present in exosomes. Finally, we demonstrate that the GD3-mediated arrest of the TCR activation is dependent upon sialic acid groups, because their enzymatic removal from exosomes or liposomes results in a loss of inhibitory capacity. Collectively, these data define GD3 as a potential immunotherapeutic target.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30446565      PMCID: PMC6289713          DOI: 10.4049/jimmunol.1801041

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer.

Authors:  Tonya J Webb; Xiangming Li; Robert L Giuntoli; Pablo H H Lopez; Christoph Heuser; Ronald L Schnaar; Moriya Tsuji; Christian Kurts; Mathias Oelke; Jonathan P Schneck
Journal:  Cancer Res       Date:  2012-05-30       Impact factor: 12.701

2.  IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells.

Authors:  Lori Broderick; Stephen P Brooks; Hiroshi Takita; Alan N Baer; Joel M Bernstein; Richard B Bankert
Journal:  Clin Immunol       Date:  2005-11-03       Impact factor: 3.969

3.  Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma.

Authors:  D F Bajorin; P B Chapman; G Wong; D G Coit; J Kunicka; J Dimaggio; C Cordon-Cardo; C Urmacher; L Dantes; M A Templeton
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

4.  Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors.

Authors:  Agnes S Y Lo; Qiangzhong Ma; David L Liu; Richard P Junghans
Journal:  Clin Cancer Res       Date:  2010-05-11       Impact factor: 12.531

5.  Extracellular Vesicles Present in Human Ovarian Tumor Microenvironments Induce a Phosphatidylserine-Dependent Arrest in the T-cell Signaling Cascade.

Authors:  Raymond J Kelleher; Sathy Balu-Iyer; Jenni Loyall; Anthony J Sacca; Gautam N Shenoy; Peng Peng; Vandana Iyer; Anas M Fathallah; Charles S Berenson; Paul K Wallace; Joseph Tario; Kunle Odunsi; Richard B Bankert
Journal:  Cancer Immunol Res       Date:  2015-06-25       Impact factor: 11.151

6.  Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.

Authors:  Johannes Landskron; Øystein Helland; Knut Martin Torgersen; Einar Martin Aandahl; Bjørn Tore Gjertsen; Line Bjørge; Kjetil Taskén
Journal:  Cancer Immunol Immunother       Date:  2014-11-22       Impact factor: 6.968

7.  Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas.

Authors:  Mark V Thornton; Daisuke Kudo; Patricia Rayman; Claudine Horton; Luis Molto; Martha K Cathcart; Christopher Ng; Ewa Paszkiewicz-Kozik; Ronald Bukowski; Ithaar Derweesh; Charles S Tannenbaum; James H Finke
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

8.  Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.

Authors:  Maurizio Perdicchio; Juan M Ilarregui; Marleen I Verstege; Lenneke A M Cornelissen; Sjoerd T T Schetters; Steef Engels; Martino Ambrosini; Hakan Kalay; Henrike Veninga; Joke M M den Haan; Lisette A van Berkel; Janneke N Samsom; Paul R Crocker; Tim Sparwasser; Luciana Berod; Juan J Garcia-Vallejo; Yvette van Kooyk; Wendy W J Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-03       Impact factor: 11.205

9.  Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma.

Authors:  R J Soiffer; P B Chapman; C Murray; L Williams; P Unger; H Collins; A N Houghton; J Ritz
Journal:  Clin Cancer Res       Date:  1997-01       Impact factor: 12.531

10.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

View more
  29 in total

1.  Investigation of substrate specificity of sialidases with membrane mimetic glycoconjugates.

Authors:  Sonia Tomar; Xue-Long Sun
Journal:  Glycoconj J       Date:  2019-12-04       Impact factor: 2.916

2.  Exposure of Keratinocytes to Candida Albicans in the Context of Atopic Milieu Induces Changes in the Surface Glycosylation Pattern of Small Extracellular Vesicles to Enhance Their Propensity to Interact With Inhibitory Siglec Receptors.

Authors:  Adrian Kobiela; Joanna E Frackowiak; Anna Biernacka; Lilit Hovhannisyan; Aleksandra E Bogucka; Kinga Panek; Argho Aninda Paul; Joanna Lukomska; Xinwen Wang; Eleni Giannoulatou; Aleksandra Krolicka; Jacek Zielinski; Milena Deptula; Michal Pikula; Susanne Gabrielsson; Graham S Ogg; Danuta Gutowska-Owsiak
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 3.  The role of miRNAs from mesenchymal stem/stromal cells-derived extracellular vesicles in neurological disorders.

Authors:  Morteza Jafarinia; Majid Reza Farrokhi; Mazdak Ganjalikhani Hakemi; William C Cho
Journal:  Hum Cell       Date:  2022-10-19       Impact factor: 4.374

4.  Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments.

Authors:  Gautam N Shenoy; Maulasri Bhatta; Jenni L Loyall; Raymond J Kelleher; Joel M Bernstein; Richard B Bankert
Journal:  Immunol Invest       Date:  2020-04-17       Impact factor: 3.657

Review 5.  Gangliosides: The Double-Edge Sword of Neuro-Ectodermal Derived Tumors.

Authors:  Sumeyye Cavdarli; Sophie Groux-Degroote; Philippe Delannoy
Journal:  Biomolecules       Date:  2019-07-27

Review 6.  Exosomes promote pre-metastatic niche formation in ovarian cancer.

Authors:  Wenlong Feng; Dylan C Dean; Francis J Hornicek; Huirong Shi; Zhenfeng Duan
Journal:  Mol Cancer       Date:  2019-08-13       Impact factor: 27.401

Review 7.  Targeting Natural Killer T Cells in Solid Malignancies.

Authors:  Zewde Ingram; Shriya Madan; Jenoy Merchant; Zakiya Carter; Zen Gordon; Gregory Carey; Tonya J Webb
Journal:  Cells       Date:  2021-05-27       Impact factor: 6.600

8.  An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8+ T Cells is Dependent on IL-10 and Independent of BRAFV600E Mutation in Melanoma Cell Lines.

Authors:  ShinLa Shu; Junko Matsuzaki; Muzamil Y Want; Alexis Conway; Shawna Benjamin-Davalos; Cheryl L Allen; Marina Koroleva; Sebastiano Battaglia; Adekunle Odunsi; Hans Minderman; Marc S Ernstoff
Journal:  Immunol Invest       Date:  2020-08-17       Impact factor: 3.044

Review 9.  Exosomes as mediators of immune regulation and immunotherapy in cancer.

Authors:  Fernanda G Kugeratski; Raghu Kalluri
Journal:  FEBS J       Date:  2020-10-03       Impact factor: 5.622

10.  Liver fluke granulin promotes extracellular vesicle-mediated crosstalk and cellular microenvironment conducive to cholangiocarcinoma.

Authors:  Patpicha Arunsan; Apisit Chaidee; Christina J Cochran; Victoria H Mann; Toshihiko Tanno; Chutima Kumkhaek; Michael J Smout; Shannon E Karinshak; Rutchanee Rodpai; Javier Sotillo; Alex Loukas; Thewarach Laha; Paul J Brindley; Wannaporn Ittiprasert
Journal:  Neoplasia       Date:  2020-03-31       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.